Answer
It treats osteoporosis in postmenopausal women and in men at high fracture risk. Its licensed fracture-risk claims differ according to the patient group.
Sources for this answer
- Risedronate sodium 35 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 1